A new trading day began on Tuesday, with Upstream Bio Inc (NASDAQ: UPB) stock price up 18.27% from the previous day of trading, before settling in for the closing price of $17.13. UPB’s price has ranged from $5.14 to $29.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 50.03%. With a float of $20.09 million, this company’s outstanding shares have now reached $53.80 million.
Upstream Bio Inc (UPB) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Upstream Bio Inc is 62.73%, while institutional ownership is 52.99%. The most recent insider transaction that took place on Oct 15 ’24, was worth 14,025,000. In this transaction Director of this company bought 825,000 shares at a rate of $17.00, taking the stock ownership to the 4,554,873 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Director bought 825,000 for $17.00, making the entire transaction worth $14,025,000. This insider now owns 4,554,873 shares in total.
Upstream Bio Inc (UPB) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -6.96 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
Upstream Bio Inc (NASDAQ: UPB) Trading Performance Indicators
Here are Upstream Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 38.27. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 401.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.05, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.98 in one year’s time.
Technical Analysis of Upstream Bio Inc (UPB)
Looking closely at Upstream Bio Inc (NASDAQ: UPB), its last 5-days average volume was 0.71 million, which is a jump from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 62.50%.
During the past 100 days, Upstream Bio Inc’s (UPB) raw stochastic average was set at 99.21%, which indicates a significant increase from 97.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.44 in the past 14 days, which was higher than the 0.98 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.14, while its 200-day Moving Average is $12.43. However, in the short run, Upstream Bio Inc’s stock first resistance to watch stands at $21.54. Second resistance stands at $22.82. The third major resistance level sits at $25.26. If the price goes on to break the first support level at $17.82, it is likely to go to the next support level at $15.38. Should the price break the second support level, the third support level stands at $14.10.
Upstream Bio Inc (NASDAQ: UPB) Key Stats
With a market capitalization of 1.09 billion, the company has a total of 53,909K Shares Outstanding. Currently, annual sales are 2,370 K while annual income is -62,810 K. The company’s previous quarter sales were 940 K while its latest quarter income was -39,970 K.
